A glimpse into the future: FDA has cleared multiple AR, VR tools for cardiology

A demonstration of SenitAR's augmented reality (AR) technology for electrophysiology lab procedures during the Heart Rhythm Society 2024 meeting. This is one of at least six FDA-cleared clinical AR and virtual reality applications that aimed at enhancing cardiology workflow and patient outcomes. Photo by Dave Fornell

A demonstration of SenitAR's augmented reality (AR) technology for electrophysiology lab procedures during the Heart Rhythm Society 2024 meeting. This is one of at least six FDA-cleared clinical AR and virtual reality applications aimed at enhancing cardiology workflow and patient outcomes. Photo by Dave Fornell.

Heart teams already have access to several augmented reality and virtual reality offerings, and many more are on the way.